Table 2.

Associations between primary syringe source and HCV seroprevalence: New England (NH, VT, MA), 2018–2019

Primary Syringe Source (Past 30 days)	Crude PR (95% CI)	Adjusted PRa,b (95% CI)
Direct SSP	0.92 (0.76–1.12)	0.89 (0.75–1.04)
Pharmacy	0.90 (0.79–1.02)	0.85 (0.73–1.00)
Indirect SSP	0.98 (0.83–1.15)	0.96 (0.82–1.13)
Other Source	reference	reference

PR Prevalence ratio; CI Confidence interval

^aAdjusted for age, gender, race, sexual orientation, incarceration, homelessness, years injecting, injection frequency, inject multiple times per sitting, inject heroin, inject cocaine, inject meth, inject speedball/screwball, ever received medication for opioid use disorder

^bn = 375